Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis

Whole brain atrophy is a putative outcome measure in monitoring relapsing‐remitting multiple sclerosis (RRMS). With the ongoing MRI transformation from 1.5T to 3T, there is an unmet need to calibrate this change. We evaluated brain parenchymal volumes (BPVs) from 1.5T versus 3T in MS and normal controls (NC).

[1]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[2]  R Bakshi,et al.  Normal Findings on Brain Fluid-Attenuated Inversion Recovery MR Images at 3T , 2009, American Journal of Neuroradiology.

[3]  Rohit Bakshi,et al.  Brain MRI Lesion Load at 1.5T and 3T versus Clinical Status in Multiple Sclerosis , 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[4]  R. Benedict,et al.  Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) , 2006, Journal of the International Neuropsychological Society.

[5]  P. Matthews,et al.  Normalized Accurate Measurement of Longitudinal Brain Change , 2001, Journal of computer assisted tomography.

[6]  D. Alsop,et al.  Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study , 2009, Journal of the Neurological Sciences.

[7]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[8]  C P Langlotz,et al.  MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5 T and 4 T. , 1998, AJNR. American journal of neuroradiology.

[9]  Mike P. Wattjes,et al.  Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T , 2006, European Radiology.

[10]  Stephen M. Smith,et al.  A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..

[11]  A. Goldszal,et al.  Estimating cerebral atrophy in multiple sclerosis patients from various MR pulse sequences , 2002, Multiple sclerosis.

[12]  A. Thompson,et al.  Method for simultaneous voxel-based morphometry of the brain and cervical spinal cord area measurements using 3D-MDEFT , 2010, Journal of magnetic resonance imaging : JMRI.

[13]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[14]  Anders M. Dale,et al.  MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths , 2009, NeuroImage.

[15]  C. Poser,et al.  Diagnostic criteria for multiple sclerosis , 2001, Clinical Neurology and Neurosurgery.

[16]  Ralph H B Benedict,et al.  Minimal Neuropsychological Assessment of MS Patients: A Consensus Approach , 2002, The Clinical neuropsychologist.

[17]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[18]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[19]  Seth E. Bouvier,et al.  Comparison of Multiple Sclerosis Lesions at 1.5 and 3.0 Tesla , 2003, Investigative radiology.

[20]  P. Lachenbruch.  Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[21]  R Turner,et al.  Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 T , 2004, NeuroImage.

[22]  D Louis Collins,et al.  Regional impact of field strength on voxel‐based morphometry results , 2009, Human brain mapping.

[23]  S. Reingold,et al.  The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment , 1999, Multiple sclerosis.

[24]  C. Crainiceanu,et al.  Quantification of multiple-sclerosis-related brain atrophy in two heterogeneous MRI datasets using mixed-effects modeling☆ , 2013, NeuroImage: Clinical.

[25]  L. Radloff.  The CES-D Scale , 1977 .

[26]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[27]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[28]  C. Jack,et al.  Comparing 3T and 1.5T MRI for Mapping Hippocampal Atrophy in the Alzheimer's Disease Neuroimaging Initiative , 2015, American Journal of Neuroradiology.

[29]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[30]  C. Kuhl,et al.  Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic mr imaging criteria for multiple sclerosis? , 2006, AJNR. American journal of neuroradiology.

[31]  R. Bakshi,et al.  Measurement of Brain and Spinal Cord Atrophy by Magnetic Resonance Imaging as a Tool to Monitor Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[32]  Richard Nicholas,et al.  Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial , 2014, The Lancet.

[33]  D. Louis Collins,et al.  Sensitivity of voxel-based morphometry analysis to choice of imaging protocol at 3 T , 2009, NeuroImage.

[34]  Mark W. Woolrich,et al.  Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.

[35]  Rohit Bakshi,et al.  Quantification of Global Cerebral Atrophy in Multiple Sclerosis from 3T MRI Using SPM: The Role of Misclassification Errors , 2014, Journal of neuroimaging : official journal of the American Society of Neuroimaging.